These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3493685)

  • 1. The treatment of Campylobacter-associated gastritis.
    McNulty CA
    Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 3. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
    McNulty CA; Gearty JC; Crump B; Davis M; Donovan IA; Melikian V; Lister DM; Wise R
    Br Med J (Clin Res Ed); 1986 Sep; 293(6548):645-9. PubMed ID: 3092967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
    Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
    Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with Campylobacter pylori in western Kentucky.
    Kraus JW; Morello PJ
    J Ky Med Assoc; 1989 Sep; 87(9):448-50. PubMed ID: 2794757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Campylobacter gastritis in young children.
    Bonamico M; Medici A; Chiesa C; Carpino F
    J Pediatr; 1989 Nov; 115(5 Pt 1):833-4. PubMed ID: 2624643
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional upper abdominal pain in Campylobacter-associated gastritis: does the patient profit from bismuth therapy?].
    Koop H
    Z Gastroenterol; 1989 Nov; 27(11):701-2. PubMed ID: 2694657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics of bismuth preparations in patients with gastritis and ulcer disease].
    Raedsch R; Walter-Sack I; Weber E; Blessing J
    Klin Wochenschr; 1990 May; 68(9):488. PubMed ID: 2355728
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
    Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
    Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of Campylobacter pylori infection].
    Börsch G
    Leber Magen Darm; 1988 Feb; 18(1):38-45. PubMed ID: 3280932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment.
    Glupczynski Y; Burette A
    Am J Gastroenterol; 1990 Jan; 85(1):98-9. PubMed ID: 2153337
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenicity of Campylobacter pylori--a causative factor in gastritis?
    McNulty CA
    Scand J Gastroenterol Suppl; 1989; 160():3-6. PubMed ID: 2683021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antibacterial treatment of Campylobacter pylori-associated gastritis in children.
    De Giacomo C; Maggiore G; Licardi G; Scotta MS; Fiocca R
    Gastroenterology; 1988 Dec; 95(6):1699. PubMed ID: 3181694
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].
    Rauws EA; Tytgat GN
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():41-3. PubMed ID: 3687150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.